Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea
· Delayed Price · Currency is KRW
25,350
+450 (1.81%)
Aug 14, 2025, 3:30 PM KST
Orum Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Aug '25 Aug 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Debt / Equity Ratio | 0.17 | 0.23 | 0.20 | 0.24 |
| Debt / EBITDA Ratio | - | - | 0.27 | - |
| Debt / FCF Ratio | - | - | 0.28 | - |
| Asset Turnover | - | 0.13 | 1.48 | - |
| Quick Ratio | 28.02 | 3.81 | 13.92 | 1.36 |
| Current Ratio | 28.33 | 3.85 | 13.95 | 1.42 |
| Return on Equity (ROE) | -8.39% | -4.57% | 97.53% | - |
| Return on Assets (ROA) | - | -3.30% | 65.28% | - |
| Return on Capital (ROIC) | -4.08% | -3.41% | 70.98% | - |
| Return on Capital Employed (ROCE) | - | - | 62.60% | - |
| Buyback Yield / Dilution | -15.33% | -20.20% | -227.30% | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.